JBCHEPHARM.BOJBCHEPHARM.BOBSE

Revenue (LTM)

$39.2B

+12.5% YoY

Net Income (LTM)

$6.6B

+19.4% YoY

Free Cash Flow

$8.0B

Revenue CAGR (5Y)

+17.6%

Marginsdeclining

FCF$8.0B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	20,058	24,242↑20.9%	31,165↑28.6%	34,842↑11.8%	39,180↑12.5%
Gross Profit	12,884	15,609↑21.1%	11,144↓28.6%	13,459↑20.8%	26,014↑93.3%
Operating Income	4,557	4,605↑1.1%	5,845↑26.9%	7,542↑29.0%	19,138↑153.8%
Net Income	4,480	3,854↓14.0%	4,098↑6.4%	5,526↑34.8%	6,596↑19.4%
EBITDA	6,723	5,815↓13.5%	7,044↑21.1%	9,335↑32.5%	10,318↑10.5%
EPS Diluted	28.98	24.91↓14.0%	26.17↑5.1%	34.85↑33.2%	41.56↑19.3%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	287	565↑97.1%	769↑36.1%	882↑14.7%	1,295↑46.7%
Total Current Assets	15,526	12,749↓17.9%	15,280↑19.9%	18,533↑21.3%	19,227↑3.7%
Total Assets	22,381	26,074↑16.5%	35,539↑36.3%	39,941↑12.4%	42,738↑7.0%
Total Current Liabilities	3,453	3,837↑11.1%	5,545↑44.5%	8,682↑56.6%	6,323↓27.2%
Total Liabilities	4,247	4,688↑10.4%	10,735↑129.0%	10,708↓0.3%	8,405↓21.5%
Total Equity	18,097	21,341↑17.9%	24,804↑16.2%	29,233↑17.9%	34,333↑17.4%
Total Debt	450	546↑21.3%	5,725↑949.2%	3,777↓34.0%	279↓92.6%
Net Debt	163	-20↓112.2%	4,955↑25059.5%	2,894↓41.6%	-1,016↓135.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	3,148	1,701↓46.0%	6,256↑267.7%	8,006↑28.0%	9,025↑12.7%
Capital Expenditure	-478	-7,068↓1379.5%	-7,650↓8.2%	-2,614↑65.8%	-976↑62.7%
Free Cash Flow	2,670	-5,367↓301.0%	-1,393↑74.0%	5,392↑487.0%	8,049↑49.3%
Stock-Based Comp	0	627	694↑10.7%	420↓39.5%	549↑30.8%
Net Change in Cash	-33	341↑1139.3%	204↓40.2%	111↓45.8%	269↑143.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance